Thin Film Electronics ASA
Oslo, 14 January 2021
This disclosure is sent on behalf of certain large shareholders in Thin Film Electronics ASA (the "Company").
Reference is made to the announcement by the Company on 6 January 2021 regarding the issuance of a total of 42,552,699 shares after conversion of warrants. Due to the issuance of new shares in the Company, certain large shareholders disclose the following information pursuant to Section 4-3 of the Norwegian Securities Trading Act and the Securities Trading Act Regulations.
Upon registration, the shareholding of Tigerstaden AS and close associates will represent 9.64% of the Company's total number of outstanding shares, holding a total of 100,347,391 shares in the Company. Furthermore, Tigerstaden AS owns 45,454,545 Warrants B with an exercise price of NOK 0.25 per share and which will be exercisable at any time until 20 August 2021 and 35,083,333 Warrants C with an exercise price of NOK 0.25 per share and which will be exercisable at any time between 31 March 2021 and 30 June 2021. All unexercised Warrants will represent 7.73% of the Company's total number of outstanding shares. All shares and unexercised Warrants combined will represent 17.37% of the Company's total number of outstanding shares.
Upon registration, the shareholding of Alden AS and close associates will represent 10.93% of the Company's total number of outstanding shares, holding a total of 113,800,000 shares in the Company. Furthermore, Alden AS owns 45,454,545 Warrants B with an exercise price of NOK 0.25 per share and which will be exercisable at any time until 20 August 2021 and 40,833,333 Warrants C with an exercise price of NOK 0.25 per share and which will be exercisable at any time between 31 March 2021 and 30 June 2021. All unexercised Warrants will represent 8.29% of the Company's total number of outstanding shares. All shares and unexercised Warrants combined will represent 19.22% of the Company's total number of outstanding shares.
This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act.
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
SkiStar AB13.12.2025 16:00:00 CET | Press release
Bulletin from Annual General Meeting of SkiStar AB
Robex Resources Inc.13.12.2025 06:31:43 CET | Press release
Robex Files Addendum to Information Circular in Connection With Amendment to Arrangement Agreement With Predictive Discovery
Teva Pharmaceutical Industries Ltd12.12.2025 22:30:00 CET | Press release
Teva Releases Q4 2025 Aide Memoire
Teva Pharmaceutical Industries Ltd12.12.2025 22:30:00 CET | Press release
Teva to Host Conference Call to Discuss Fourth Quarter 2025 Financial Results at 8 a.m. ET on January 28, 2026
Ingredion Incorporated12.12.2025 22:06:36 CET | Press release
Ingredion Incorporated Declares Quarterly Dividend of $0.82 Per Share
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
